Related Experiment Video
Updated: Jul 5, 2025
09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.7K
Mitogen-Activated Protein Kinase 15 Is a New Predictive Biomarker and Potential Therapeutic Target for Ovarian Cancer
Qiu-Hua Zhong1, Andy T Y Lau1, Yan-Ming Xu1
1Laboratory of Cancer Biology and Epigenetics, Department of Cell Biology and Genetics, Shantou University Medical College, Shantou 515041, China.
International Journal of Molecular Sciences
|January 11, 2024
Summary
Mitogen-activated protein kinase 15 (MAPK15) expression is linked to ovarian cancer progression. High MAPK15 levels indicate a better prognosis and increased drug sensitivity, suggesting its potential as a biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Mitogen-activated protein kinase 15 (MAPK15) is implicated in various cancers.
- Its role in ovarian carcinoma progression and drug response remains largely unexplored.
Purpose of the Study:
- To investigate the association between MAPK15 expression and ovarian cancer progression.
- To evaluate MAPK15's impact on drug responsiveness and patient prognosis in ovarian carcinoma.
Main Methods:
- Immunohistochemistry (IHC) on ovarian tissue arrays.
- MTS assay for drug sensitivity in ovarian cancer cell lines (OVCAR3, SKOV3).
- Immunoblot, real-time PCR, Kaplan-Meier Plotter, and GEO datasets for expression analysis and prognostic value.
Main Results:
- MAPK15 expression negatively correlated with tumor grade, TNM stage, tumor size, and lymph node metastasis.
- Overexpression of MAPK15 enhanced cisplatin sensitivity in ovarian cancer cells.
- High MAPK15 expression was associated with favorable patient prognosis, irrespective of chemotherapy.
Conclusions:
- Decreased MAPK15 expression is linked to advanced ovarian cancer and poor survival outcomes.
- MAPK15 shows potential as a novel biomarker for ovarian cancer.
- Targeting MAPK15 expression may offer a promising therapeutic strategy.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:38Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:07MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
01:22PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K